What does Hawkins, Inc. do?
Hawkins, Inc. is a U.S. water treatment and specialty ingredients company listed on Nasdaq under the ticker HWKN. It formulates, manufactures, blends, repackages, distributes, and services chemicals and ingredients for municipal water systems, industrial facilities, food and nutrition manufacturers, pharmaceutical customers, and agricultural markets. The company describes itself in its fiscal 2026 Form 10-K as a leading water treatment and specialty ingredients business.
Three operating segments with shared chemistry
The operating structure is more integrated than the segment labels imply. Water Treatment sells chemistry, filtration media, equipment, rental systems, engineering, and field service. Food and Health Sciences supplies nutrition, food, pharmaceutical, and agricultural ingredients, with formulation, sourcing, processing, blending, and quality-control capabilities. Industrial Solutions distributes and processes acids, alkalis, and other industrial chemicals. Shared raw materials, terminals, manufacturing assets, and purchasing relationships create scale economies across the three businesses.
| Segment | Core customers | What Hawkins sells | Economic role |
|---|---|---|---|
| Water Treatment | Municipalities, industrial water users, pools, agriculture | Chemicals, filtration media, tanks, valves, pumps, rentals, engineered systems | Largest and fastest-growing segment; service density supports recurring demand |
| Food and Health Sciences | Nutrition, food, pharmaceutical, and agricultural manufacturers | Minerals, vitamins, amino acids, excipients, sweeteners, enzymes, salts, fertilizers | Specialty ingredient platform with higher compliance and formulation requirements |
| Industrial Solutions | Manufacturing, chemical processing, electronics, energy, plating | Acids, alkalis, bulk storage, custom blending, repackaging, terminal services | Infrastructure-heavy distribution base that shares procurement and facilities |
Customers, geography, and why the company matters
Hawkins is primarily a domestic company: substantially all revenue and long-lived assets are in the United States, and no single customer represented 10% or more of fiscal 2026 sales. Water Treatment alone operated from 53 warehouses in 28 states at fiscal year-end, mainly across the eastern two-thirds of the country. That footprint matters because chemicals are heavy, delivery-sensitive products, while municipal and industrial customers often need technical support rather than a simple shipment. Hawkins' local route and technician model combines logistics, sales, service, and troubleshooting in one customer relationship.
How does Hawkins make money, and which segment matters most?
Hawkins earns revenue mainly by selling physical products, but its economics depend on how much value it adds before delivery. Bulk commodity chemicals carry lower margins because Hawkins receives, stores, and ships them with limited modification. Manufactured, blended, repackaged, formulated, and service-supported products usually provide better economics because customers pay for smaller package sizes, specialized chemistry, reliability, technical expertise, equipment support, and local availability.
Revenue mechanics by segment
Why Water Treatment is now the center of gravity
Water Treatment is important not only because it is largest, but because its revenue has a service component and a local density advantage. Hawkins can supply routine chemistry, diagnose system problems, maintain pumps and tanks, and expand into filtration systems. The equipment and service offering broadens the relationship beyond chemical resale and creates more cross-selling opportunities after an acquisition.
What does Hawkins' latest reporting period show?
As of July 25, 2026, the latest reported financial package is the fourth quarter and full fiscal year ended March 29, 2026. Hawkins has scheduled its first-quarter fiscal 2027 release for July 29, 2026, so the figures below are the freshest official results currently available. The fiscal 2026 earnings release shows strong sales and cash-flow growth, but also illustrates how acquisition-related amortization and interest can pressure earnings per share.
Fourth-quarter signal: sales rose, but acquisition costs diluted EPS
Fourth-quarter Water Treatment sales increased 16% to $122.3 million, including $13.1 million of acquired revenue. Food and Health Sciences sales were nearly flat at $88.6 million, while Industrial Solutions increased 6% to $55.0 million. The company said the $0.04 decline in diluted EPS primarily reflected about $4.4 million of additional amortization, interest expense, and WaterSurplus earnout accretion. That distinction matters: the underlying operations expanded, while financing and purchase-accounting costs absorbed part of the benefit.
Full-year signal: scale improved faster than net earnings
| Metric | FY2026 | FY2025 | Interpretation |
|---|---|---|---|
| Revenue | $1,083.7M | $974.4M | Up 11%, led by acquired and organic Water Treatment growth |
| Gross profit | $245.1M | $225.5M | Up 9%; gross margin eased to 22.6% from 23.1% |
| Operating income | $121.3M | $119.2M | Up 2%; SG&A and amortization limited operating leverage |
| Net income | $81.5M | $84.3M | Down 3%; interest expense rose to $13.5M from $5.4M |
| Diluted EPS | $3.91 | $4.03 | Lower despite revenue growth because financing and amortization increased |
| Operating cash flow | $144.3M | $111.1M | Up 30%, helped by favorable inventory and receivable movements |
Which turning points created today's Hawkins?
Hawkins' history is best understood as a gradual move from regional bulk chemical distribution toward a denser, more specialized platform. The official company history begins in 1938, but the most important modern turning points are acquisitions and operating investments that changed segment mix, geography, and technical capability.
Strategic timeline
-
1938Hawkins was founded. The long operating history helped build supplier relationships, chemical-handling expertise, and a customer-service culture that still supports the distribution model.
-
2015The $157.0 million acquisition of Stauber Performance Ingredients created the Health and Nutrition platform, adding specialty ingredients, new facilities, and regulated end markets.
-
2021NAPCO Chemical added three Texas water treatment locations, demonstrating the repeatable strategy of buying regional operators and connecting them to Hawkins' procurement and operating network.
-
2023-2024Water Solutions Unlimited, Miami Products, EcoTech, Industrial Research, Intercoastal, Wofford, Waterguard, and other acquisitions expanded the eastern and southern footprint and increased route density.
-
April 2025WaterSurplus was acquired for $149.9 million at closing, plus a potential earnout of up to $53.7 million. It added filtration systems, rental capability, and water-reuse technology, not just more chemical distribution.
-
Fiscal 2026Five smaller acquisitions beyond WaterSurplus added Texas and Alabama distribution, coagulants, corrosion-control products, equipment, and a lactate business. Hawkins reported 17 acquisitions over five years.
-
April 2026Aqua-Chem extended commercial-pool chemistry, equipment, and service into Nebraska and Iowa, continuing the geographic fill-in strategy after fiscal year-end.
Why acquisition integration matters more than deal count
The strategy works only if Hawkins converts local acquisitions into denser routes, broader product offerings, and shared purchasing and infrastructure. WaterSurplus is the clearest test because it was much larger than a typical tuck-in and brought a different mix of equipment, rentals, engineering, and technology. The official acquisition announcement framed it as a complementary expansion of water treatment solutions.
Water treatment density and service define the competitive position
Hawkins does not possess a classic patent monopoly or consumer brand moat. Its advantage is operational: local physical assets, trained technicians, chemical-handling compliance, purchasing relationships, broad product availability, and the ability to solve a customer's problem quickly. These resources are individually replicable, but the combined network is harder to reproduce in a fragmented regional market.
Local density as a service moat
A municipal operator may value a lower unit price, but it also needs correct dosing, safe handling, on-time delivery, regulatory documentation, and emergency responsiveness. Hawkins' route employees often act as driver, salesperson, and technician. That design raises switching friction because the relationship includes operating knowledge and service history. It also creates a practical advantage over distant suppliers that may offer chemicals without comparable local support.
The economic trade-off: resilience versus physical intensity
The same assets that support the moat require capital. Warehouses, terminals, tanks, trucks, safety systems, and working inventory tie up cash. Fiscal 2026 capital expenditures reached $58.2 million, and working-capital timing can move operating cash flow materially because Hawkins buys large quantities of bulk chemicals. The model is therefore more defensible than pure brokerage but less asset-light than a software or licensing business.
Who competes with Hawkins, and what protects the business?
Hawkins' 10-K does not identify one dominant rival because competition varies by product, region, and customer. The practical set includes global distributors such as Brenntag and Univar Solutions, suppliers such as Chemtrade, regional distributors, local water-treatment specialists, ingredient distributors, and producers' direct sales organizations. Hawkins competes on price, quality, availability, reach, technical expertise, delivery speed, breadth, and service.
Competitive pressure and differentiation
| Competitive group | Typical advantage | Hawkins response | Main vulnerability |
|---|---|---|---|
| Global distributors | Broader catalogs, international sourcing, purchasing scale | Local technician model, smaller-customer responsiveness, regional density | Larger competitors can withstand commodity and freight volatility |
| Chemical producers | Manufacturing control and direct economics | Multi-supplier sourcing, repackaging, blending, and last-mile delivery | Supplier concentration or direct-selling decisions can change terms |
| Regional water specialists | Local relationships and niche expertise | Acquire and integrate them, then add procurement and product breadth | Overpaying or losing local talent can weaken acquisition returns |
| Ingredient distributors | Specialized portfolios and application expertise | Stauber platform, compliance processes, formulation, and national sales | Food and nutrition pricing pressure can compress gross profit |
Hawkins' strongest protection is customer relevance across multiple dimensions. A competitor must match not only the chemical price but also supply assurance, packaging, technical support, local delivery, equipment capability, and compliance. Still, the company explicitly warns that larger rivals may have more financial resources, products, and geographic reach. The moat is therefore durable only if service quality remains high and the route network continues to become more efficient.
How financially strong is Hawkins after its acquisition push?
Fiscal 2026 shows a company with strong operating cash generation but a meaningfully more leveraged balance sheet. WaterSurplus and smaller acquisitions expanded assets, goodwill, intangible assets, and debt. Hawkins remains within its credit covenants and reported a modest pro forma leverage ratio, yet the financial story now depends more heavily on integration and debt paydown than it did before the large acquisition.
Cash generation versus debt burden
Total assets increased to $986.3 million from $770.0 million, shareholders' equity rose to $534.0 million, and debt increased to $244.0 million from $149.0 million. The $400 million revolving facility matures in April 2030, carried an effective 4.4% rate at fiscal year-end, and requires a minimum 1.15x fixed-charge coverage ratio and a maximum 3.0x cash-flow leverage ratio. Hawkins reported compliance and expects to approach roughly 1x leverage by the end of fiscal 2027.
Capital allocation is balancing growth, infrastructure, dividends, and deleveraging
| Use or source of cash | FY2026 amount | What it signals |
|---|---|---|
| Operating cash flow | $144.3M | Core operations produced substantial cash despite integration activity |
| Acquisition spending | $167.1M | Water Treatment expansion remained the largest strategic use of capital |
| Capital expenditures | $58.2M | Real estate purchases and facility expansion increased physical capacity |
| Cash dividends | $15.7M | Dividend continuity remained part of shareholder return; $0.75 per share was paid |
| Net debt borrowings | $95.0M | External financing bridged the gap between internal cash and expansion spending |
| Share repurchases | $0 | Buybacks paused while acquisition and infrastructure spending took priority |
Who owns Hawkins stock, and how is the company governed?
Hawkins has one class of common stock with one vote per share and no cumulative voting for directors. That means economic ownership and voting power are broadly aligned. The investor base is institutionally concentrated, but the company is not founder-controlled. The latest 2026 proxy statement reported 20,906,400 shares outstanding on the June 5, 2026 record date.
Ownership concentration and voting influence
| Holder or group | Shares | Stake | Why it matters |
|---|---|---|---|
| BlackRock, Inc. | 3,160,991 | 15.1% | Largest disclosed holder; institutional voting can influence governance outcomes |
| Kayne Anderson Rudnick Investment Management | 1,526,155 | 7.3% | Meaningful active institutional position in a relatively small public float |
| State Street Corporation | 1,043,806 | 5.0% | Another major institutional block with standard proxy-voting influence |
| All directors and executive officers | 774,160 | 3.7% | Provides insider alignment without effective voting control |
| Patrick H. Hawkins, CEO | 347,800 | 1.7% | Meaningful personal ownership, but institutions remain the dominant voting force |
Leadership continuity with an independent board
Patrick H. Hawkins has worked at the company since 1992 and has served as chief executive since 2011, giving management unusually deep operating knowledge. The board has eight directors, six of whom the company classifies as independent under Nasdaq standards. Executive incentives use company pretax income and, for segment leaders, business-unit profitability. That design is relevant because it rewards profit delivery rather than revenue growth alone, although acquisition accounting and capital efficiency still require separate investor scrutiny.
What opportunities, risks, and KPIs should researchers monitor?
The forward case depends on whether Hawkins can compound Water Treatment through organic growth and disciplined acquisitions while keeping margins, safety, and leverage under control. The downside case is not simply lower chemical demand; it includes poor integration, raw-material price lags, environmental liabilities, operational incidents, intangible-asset impairment, and a physical network that requires continuous investment.
Growth opportunities with measurable checkpoints
Risks tied to specific financial lines
| Risk | Evidence or exposure | Financial line to monitor | Interpretation |
|---|---|---|---|
| Raw-material volatility | Hawkins may face delays passing price increases to customers | Gross profit dollars and LIFO effect | FY2026 LIFO changes reduced gross profit by $1.5M |
| Acquisition integration | WaterSurplus and multiple tuck-ins expanded systems and geography | Organic growth, SG&A, amortization, earnout liability | Acquired revenue is valuable only if margins and customer retention persist |
| Leverage and rates | $244.0M of variable-rate revolver debt at March 29, 2026 | Interest expense, leverage ratio, free cash flow | Interest expense more than doubled to $13.5M in FY2026 |
| Environmental and safety exposure | Chemical storage, handling, transport, spills, and remediation obligations | Environmental liabilities, insurance, capex, downtime | Compliance is part of the moat but can create large episodic costs |
| Goodwill and intangible impairment | $455.9M combined carrying value at March 29, 2026 | Amortization and impairment charges | A weaker acquired business could reduce earnings and equity without immediate cash outflow |
| Facility and lease dependence | Four key facility land leases expire between 2029 and 2044 | Relocation capex and operating disruption | Terminal location is operationally important because bulk chemicals are costly to move |
DCF drivers and the next reported checkpoint
A Hawkins DCF should focus on revenue quality rather than a single top-line growth assumption. Key inputs are organic Water Treatment growth, acquisition contribution, gross profit dollars, SG&A integration, capital expenditures, working-capital needs, cash interest, and the speed of debt reduction. Terminal assumptions should reflect a resilient but capital-intensive domestic distribution and service model, not a high-margin asset-light platform.
The immediate checkpoint is the first-quarter fiscal 2027 release scheduled for July 29, 2026 on Hawkins' investor relations page. The most informative items will be Water Treatment organic growth, WaterSurplus integration costs, Food and Health Sciences pricing, operating cash flow, capex, and the leverage ratio.
The key analytical takeaway for Hawkins
Hawkins has evolved into a scaled regional platform whose central asset is a dense water treatment network supported by chemical procurement, manufacturing, blending, logistics, equipment, and technical service. Fiscal 2026 demonstrated the strength of that model: revenue exceeded $1 billion, Water Treatment reached half of company sales, and operating cash flow rose 30%. It also exposed the main strategic tension: acquisition-led scale increased debt, interest, amortization, and intangible assets faster than net income.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.